MetLife Inc
NYSE:MET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MetLife Inc
NYSE:MET
|
US |
|
HMS Networks AB
STO:HMS
|
SE |
|
Indo Global Exchange(s) Pte Ltd
OTC:IGEX
|
ID |
|
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
|
TW |
|
Oryzon Genomics SA
F:ORN
|
ES |
|
Oaktree Specialty Lending Corp
F:FFC0
|
US |
|
CD Projekt SA
F:7CD
|
PL |
|
Swiss Water Decaffeinated Coffee Inc
TSX:SWP
|
CA |
|
Autoneum Holding AG
OTC:ATNNF
|
CH |
|
Jinli Group Holdings Ltd
TWSE:8429
|
KY |
Intrinsic Value
Is MET undervalued or overvalued?
See the intrinsic value estimate for MetLife Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MET looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MET’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What MetLife Does
MetLife is a large insurance and employee benefits company. It sells life insurance, annuities, dental and vision coverage, disability insurance, and other protection products that help people and families manage financial risk. It also serves employers that want group insurance and retirement-related benefits for their workers.
- Headquarters
- United States of America US
- Employees
- 46 000
- IPO date
- Apr 5, 2000
MetLife has no economic moat
Employers and individuals can choose among many insurers offering similar coverage, and MetLife’s name does not by itself make customers willing to pay more. Its size and range of products do not prevent rivals from competing for the same customers.
Read the full moat analysis
The intrinsic value for MetLife Inc (MET) under the Base Case is hidden USD.
Compared with the current market price of 98.99 USD, the stock appears hidden.